RIVM, Bilthoven, The Netherlands.
Int J Technol Assess Health Care. 2013 Jan;29(1):20-6. doi: 10.1017/S0266462312000694. Epub 2013 Jan 7.
This study aimed to investigate the technical documentation of manufacturers on issues of safe use of their device in a home setting.
Three categories of equipment were selected: infusion pumps, ventilators, and dialysis systems. Risk analyses, instructions for use, labels, and post market surveillance procedures were requested from manufacturers. Additionally, they were asked to fill out a questionnaire on collection of field experience, on incidents, and training activities.
Specific risks of device operation by lay users in a home setting were incompletely addressed in the risk analyses. A substantial number of user manuals were designed for professionals, rather than for patients or lay carers. Risk analyses and user information often showed incomplete coherence. Post market surveillance was mainly based on passive collection of field experiences.
Manufacturers of infusion pumps, ventilators, and dialysis systems pay insufficient attention to the specific risks of use by lay persons in home settings. It is expected that this conclusion is also applicable for other medical equipment for treatment at home. Manufacturers of medical equipment for home use should pay more attention to use errors, lay use and home-specific risks in design, risk analysis, and user information. Field experiences should be collected more actively. Coherence between risk analysis and user information should be improved. Notified bodies should address these aspects in their assessment. User manuals issued by institutions supervising a specific home therapy should be drawn up in consultation with the manufacturer.
本研究旨在调查制造商关于其设备在家中安全使用问题的技术文件。
选择了三类设备:输液泵、呼吸机和透析系统。向制造商请求风险分析、使用说明、标签和上市后监测程序。此外,还要求他们填写一份关于现场经验收集、事件和培训活动的问卷。
在风险分析中,未充分解决非专业人员在家中使用设备的特定风险。大量用户手册是为专业人员设计的,而不是为患者或非专业护理人员设计的。风险分析和用户信息往往显示出不完全的一致性。上市后监测主要基于被动收集现场经验。
输液泵、呼吸机和透析系统的制造商对非专业人员在家中使用设备的特定风险关注不够。预计这一结论也适用于其他用于家庭治疗的医疗设备。用于家庭使用的医疗设备制造商应更加关注设计、风险分析和用户信息中的使用错误、非专业使用和家庭特定风险。应更积极地收集现场经验。应改进风险分析和用户信息之间的一致性。通知机构应在其评估中解决这些方面。机构监督特定家庭治疗的用户手册应由制造商协商制定。